These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10216468)

  • 1. Beneficial treatment of patients with advanced cancer using a Newcastle disease virus vaccine (MTH-68/H).
    Csatary LK; Moss RW; Beuth J; Töröcsik B; Szeberenyi J; Bakacs T
    Anticancer Res; 1999; 19(1B):635-8. PubMed ID: 10216468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newcastle disease virus-infected intact autologous tumor cell vaccine for adjuvant active specific immunotherapy of resected colorectal carcinoma.
    Ockert D; Schirrmacher V; Beck N; Stoelben E; Ahlert T; Flechtenmacher J; Hagmüller E; Buchcik R; Nagel M; Saeger HD
    Clin Cancer Res; 1996 Jan; 2(1):21-8. PubMed ID: 9816085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the apoptosis inhibitor protease inhibitor 9 predicts clinical outcome in vaccinated patients with stage III and IV melanoma.
    van Houdt IS; Oudejans JJ; van den Eertwegh AJ; Baars A; Vos W; Bladergroen BA; Rimoldi D; Muris JJ; Hooijberg E; Gundy CM; Meijer CJ; Kummer JA
    Clin Cancer Res; 2005 Sep; 11(17):6400-7. PubMed ID: 16144945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuated veterinary virus vaccine for the treatment of cancer.
    Csatary LK; Eckhardt S; Bukosza I; Czegledi F; Fenyvesi C; Gergely P; Bodey B; Csatary CM
    Cancer Detect Prev; 1993; 17(6):619-27. PubMed ID: 8275514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of apoptosis by a Newcastle disease virus vaccine (MTH-68/H) in PC12 rat phaeochromocytoma cells.
    Fábián Z; Töröcsik B; Kiss K; Csatary LK; Bodey B; Tigyi J; Csatary C; Szeberényi J
    Anticancer Res; 2001; 21(1A):125-35. PubMed ID: 11299726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen-based immunotherapy of melanoma: Canvaxin therapeutic polyvalent cancer vaccine.
    Hsueh EC; Morton DL
    Semin Cancer Biol; 2003 Dec; 13(6):401-7. PubMed ID: 15001158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic cell immunotherapy for stage IV melanoma.
    O'Rourke MG; Johnson MK; Lanagan CM; See JL; O'Connor LE; Slater GJ; Thomas D; Lopez JA; Martinez NR; Ellem KA; Schmidt CW
    Melanoma Res; 2007 Oct; 17(5):316-22. PubMed ID: 17885587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bolus high dose interleukin-2 for the treatment of malignant melanoma.
    Pappo I; Lotem M; Klein M; Orda R
    Isr Med Assoc J; 2001 Mar; 3(3):169-73. PubMed ID: 11303372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune responses in the draining lymph nodes against cancer: implications for immunotherapy.
    Shu S; Cochran AJ; Huang RR; Morton DL; Maecker HT
    Cancer Metastasis Rev; 2006 Jun; 25(2):233-42. PubMed ID: 16770535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized phase II study of SRL172 (Mycobacterium vaccae) combined with chemotherapy in patients with advanced inoperable non-small-cell lung cancer and mesothelioma.
    O'Brien ME; Saini A; Smith IE; Webb A; Gregory K; Mendes R; Ryan C; Priest K; Bromelow KV; Palmer RD; Tuckwell N; Kennard DA; Souberbielle BE
    Br J Cancer; 2000 Oct; 83(7):853-7. PubMed ID: 10970684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind trial of a polyvalent, shed-antigen, melanoma vaccine.
    Bystryn JC; Zeleniuch-Jacquotte A; Oratz R; Shapiro RL; Harris MN; Roses DF
    Clin Cancer Res; 2001 Jul; 7(7):1882-7. PubMed ID: 11448900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot clinical trial of vaccination with dendritic cells pulsed with autologous tumor cells derived from malignant pleural effusion in patients with late-stage lung carcinoma.
    Chang GC; Lan HC; Juang SH; Wu YC; Lee HC; Hung YM; Yang HY; Whang-Peng J; Liu KJ
    Cancer; 2005 Feb; 103(4):763-71. PubMed ID: 15637694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Important antitumoral immunity and a favorable clinical outcome in two patients receiving an autologous vaccine].
    Baurain JF
    Bull Mem Acad R Med Belg; 2003; 158(5-6):299-307. PubMed ID: 15025271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of clinical trials with an allogenic melanoma tumor cell lysate vaccine: Melacine.
    Sondak VK; Sosman JA
    Semin Cancer Biol; 2003 Dec; 13(6):409-15. PubMed ID: 15001159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine therapy for melanoma: current status and future directions.
    Terando AM; Faries MB; Morton DL
    Vaccine; 2007 Sep; 25 Suppl 2():B4-16. PubMed ID: 17646038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical phase I intratumoral administration of two recombinant ALVAC canarypox viruses expressing human granulocyte-macrophage colony-stimulating factor or interleukin-2: the transgene determines the composition of the inflammatory infiltrate.
    Hofbauer GF; Baur T; Bonnet MC; Tartour E; Burg G; Berinstein NL; Dummer R
    Melanoma Res; 2008 Apr; 18(2):104-11. PubMed ID: 18337646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of stage II malignant melanoma patients with a Newcastle disease virus oncolysate.
    Cassel WA; Murray DR
    Nat Immun Cell Growth Regul; 1988; 7(5-6):351-2. PubMed ID: 3065642
    [No Abstract]   [Full Text] [Related]  

  • 18. Dendritic-cell vaccination for metastatic melanoma?
    Chen V
    Lancet Oncol; 2006 May; 7(5):368. PubMed ID: 16696162
    [No Abstract]   [Full Text] [Related]  

  • 19. Dendritoma vaccination combined with low dose interleukin-2 in metastatic melanoma patients induced immunological and clinical responses.
    Wei Y; Sticca RP; Holmes LM; Burgin KE; Li J; Williamson J; Evans L; Smith SJ; Stephenson JJ; Wagner TE
    Int J Oncol; 2006 Mar; 28(3):585-93. PubMed ID: 16465362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphatic mapping and sentinel lymphadenectomy for melanoma: past, present, and future.
    Morton DL
    Ann Surg Oncol; 2001 Oct; 8(9 Suppl):22S-28S. PubMed ID: 11599892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.